Hepatitis SA invites you to The 2018 HepLINK Forum: Engaging Marginalised Populations in Hepatitis C Treatment
Thjis will be held on Thursday, 1 March, 11am–2pm (lunch provided), at the Education Development Centre (EDC), 4 Milner St, Hindmarsh.
Keynote speaker: Dr Phillip Read, Director, Kirketon Road Centre
Dr Phillip Read is a sexual health physician and the Director of the Kirketon Road Centre in Sydney’s Kings Cross. Kirketon Road is a primary health care facility involved in the prevention, treatment and care of HIV, hepatitis and STIs among people who inject drugs, sex workers and at-risk young people.
Rosalie Altus, Practice Consultant Viral Hepatitis Liaison Nurse, Flinders Medical Centre
Panel discussion with guest speakers representing the Aboriginal, youth, regional, multicultural and CNP sectors across South Australia
A clinical trial is now open for people who have been diagnosed with chronic Hepatitis B Virus (HBV) infection, who have not had treatment for this condition in the last 2 years. Other entry requirements apply.
The purpose of this research study is to assess the effectiveness and safety of a novel medicine for the treatment of patients with chronic Hepatitis B. Participating clinics include leading hospitals and medical centres.
If you live in South Australia, and are interested to participate, contact the Study Coordinators at the Royal Adelaide Hospital.
This upcoming Heplink forum focuses on hepatitis C treatments – past, present and future.
Hear from speakers about treatment advocacy, support models, treatment experiences (including excerpts from a video diary), and an update on all the treatments currently submitted for listing on the Pharmaceutical Benefits Scheme and what these treatments will mean for South Australia.